Female sexual interest/arousal disorderIn the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, when female sexual interest/arousal disorder is transmitted , the interpersonal context must be taken into account. In desire discrepancy where a woman has a lower desire for sexual activities and for her partner, it is not enough to diagnose female sexual interest/sexual arousal disorder for the criteria for the disorder to be met, there must be absence or reduced frequency or intensity of at least three of the six indicators (criterion A) for a minimum duration of approximately 6 months (criterion B). There may be different symptom profiles among women, as well as variability in how sexual interest and arousal are expressed. For example, in a woman, sexual interest/arousal disorder may be expressed as lack of interest in sexual activity, absence of erotic or sexual thoughts, and reluctance to initiate sexual activity and respond to a partner's sexual invitations. In other women, the main features may be the inability to become sexually aroused, to respond to sexual stimuli with sexual desire, and the corresponding lack of signs of physical sexual arousal. Presenter, Because sexual desire and arousal often coexist and are aroused in response to appropriate sexual causes, the criteria for female sexual interest/arousal disorder take into account the difficulties in desire and arousal that often simultaneously characterize the disorders of women with this disorder. In the short term, changes in sexual interest or arousal are common and perhaps adaptive responses to events in a woman's life and do not represent sexual dysfunction. The diagnosis of female sexual interest/arousal disorder requires a minimum duration of symptoms of approximately... half of the paper... ey, JK, Davis, MC, & Bakhta, Y. (2010). Orgasm disorders in women: a review of the literature on etiology and current treatments. Journal of Sexual Medicine, 7(10), 3254-3268. doi:10.1111/j.1743-6109.2010.01928.x http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=66324923&site=ehost-live Laan, E., Rellini, A.H., & Barnes, T. (2013). Standard operating procedures for female orgasmic disorder: Consensus of the International Society of Sexual Medicine. Journal of Sexual Medicine, 10(1), 74-82. doi:10.1111/j.1743-6109.2012.02880.x http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=85040398&site=ehost-live Safarinejad MR. (2008). Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorders: a randomized double-blind, placebo-controlled, fixed-dose study. J Sex Med 2008; 5:887–97.